Cite
Selective Cell Penetrating Peptide-Functionalized Envelope-Type Chimeric Lipopepsomes Boost Systemic RNAi Therapy for Lung Tumors.
MLA
Qiu, Min, et al. “Selective Cell Penetrating Peptide-Functionalized Envelope-Type Chimeric Lipopepsomes Boost Systemic RNAi Therapy for Lung Tumors.” Advanced Healthcare Materials, vol. 8, no. 16, Aug. 2019, p. e1900500. EBSCOhost, https://doi.org/10.1002/adhm.201900500.
APA
Qiu, M., Ouyang, J., Wei, Y., Zhang, J., Lan, Q., Deng, C., & Zhong, Z. (2019). Selective Cell Penetrating Peptide-Functionalized Envelope-Type Chimeric Lipopepsomes Boost Systemic RNAi Therapy for Lung Tumors. Advanced Healthcare Materials, 8(16), e1900500. https://doi.org/10.1002/adhm.201900500
Chicago
Qiu, Min, Jia Ouyang, Yaohua Wei, Jian Zhang, Qing Lan, Chao Deng, and Zhiyuan Zhong. 2019. “Selective Cell Penetrating Peptide-Functionalized Envelope-Type Chimeric Lipopepsomes Boost Systemic RNAi Therapy for Lung Tumors.” Advanced Healthcare Materials 8 (16): e1900500. doi:10.1002/adhm.201900500.